Literature DB >> 26432443

Gingival epithelial cells support osteoclastogenesis by producing receptor activator of nuclear factor kappa B ligand via protein kinase A signaling.

M Usui1,2, T Sato3, G Yamamoto4, Y Okamatsu5, T Hanatani1, Y Moritani1, K Sano1, M Yamamoto2, K Nakashima1.   

Abstract

BACKGROUND AND
OBJECTIVE: Periodontal disease is dental plaque-induced inflammatory disease of the periodontal tissues that results in bone loss in the affected teeth. During bone resorption, receptor activator of nuclear factor kappa B ligand (RANKL) is an essential factor that regulates osteoclastogenesis. Recently, we found that gingival epithelial cells (GECs) in periodontal tissue produce RANKL, the expression of which is regulated by tumor necrosis factor-α and protein kinase A signaling. In this study, we asked whether RANKL-producing GECs induce bone marrow macrophages (BMMs) to form osteoclasts in a co-culture system.
MATERIAL AND METHODS: Ca9-22 GECs and osteoclast precursor BMMs were co-cultured with or without the protein kinase A signaling activator forskolin or inhibitor H89 to examine whether the RANKL-producing GECs could be induced to form osteoclasts, as determined using a pit formation assay.
RESULTS: Osteoclasts formed spontaneously in co-cultures of Ca9-22 cells and BMMs, even in the absence of RANKL. The cells were cultured on bone slices for 14 d, at which time resorption pits were observed. Forskolin treatment significantly increased osteoclast numbers in these co-cultures, but forskolin alone did not induce osteoclast formation by BMMs.
CONCLUSION: GECs producing RANKL are able to support osteoclastogenesis in an in vitro co-culture system using GECs and BMMs, in a process promoted by forskolin.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  PKA signaling; RANKL; gingival epithelial cell; osteoclast

Mesh:

Substances:

Year:  2015        PMID: 26432443     DOI: 10.1111/jre.12323

Source DB:  PubMed          Journal:  J Periodontal Res        ISSN: 0022-3484            Impact factor:   4.419


  7 in total

Review 1.  RANKL and osteoimmunology in periodontitis.

Authors:  Masayuki Tsukasaki
Journal:  J Bone Miner Metab       Date:  2020-10-17       Impact factor: 2.626

2.  Interleukin-33 and RANK-L Interplay in the Alveolar Bone Loss Associated to Periodontitis.

Authors:  Olivier Lapérine; Alexandra Cloitre; Jocelyne Caillon; Olivier Huck; Isaac Maximiliano Bugueno; Paul Pilet; Sophie Sourice; Elodie Le Tilly; Gaby Palmer; Jean-Luc Davideau; Valérie Geoffroy; Jérôme Guicheux; Sarah Beck-Cormier; Philippe Lesclous
Journal:  PLoS One       Date:  2016-12-19       Impact factor: 3.240

3.  IL-36γ is a pivotal inflammatory player in periodontitis-associated bone loss.

Authors:  Alexandra Cloitre; Boris Halgand; Sophie Sourice; Jocelyne Caillon; Olivier Huck; Isaac Maximiliano Bugueno; Fareeha Batool; Jérôme Guicheux; Valérie Geoffroy; Philippe Lesclous
Journal:  Sci Rep       Date:  2019-12-17       Impact factor: 4.379

4.  Co-cultured spheroids of human periodontal ligament mesenchymal stem cells and vascular endothelial cells enhance periodontal tissue regeneration.

Authors:  Kotaro Sano; Michihiko Usui; Yuki Moritani; Kohji Nakazawa; Tomoya Hanatani; Hisataka Kondo; Mitsushiro Nakatomi; Satoru Onizuka; Takanori Iwata; Tsuyoshi Sato; Akifumi Togari; Wataru Ariyoshi; Tatsuji Nishihara; Keisuke Nakashima
Journal:  Regen Ther       Date:  2020-01-14       Impact factor: 3.419

Review 5.  Oral Osteomicrobiology: The Role of Oral Microbiota in Alveolar Bone Homeostasis.

Authors:  Xingqun Cheng; Xuedong Zhou; Chengcheng Liu; Xin Xu
Journal:  Front Cell Infect Microbiol       Date:  2021-11-17       Impact factor: 5.293

6.  Comparative Analysis of Cytokine Expression in Oral Keratinocytes and THP-1 Macrophages in Response to the Most Prevalent Serotypes of Aggregatibacter actinomycetemcomitans.

Authors:  Daniel Betancur; Camila Muñoz Grez; Angel Oñate
Journal:  Microorganisms       Date:  2021-03-17

7.  Gingival cell growth with antiresorptive treatment combined with corticosteroids or antiestrogen.

Authors:  Heidi M Ekholm; Eliisa Löyttyniemi; Tero Soukka; Jaana Rautava
Journal:  Clin Exp Dent Res       Date:  2021-01-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.